AIM ImmunoTech Inc. (AIM)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 19.49M |
| Enterprise value | 12.58M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 96.18 |
| Price/book (mrq) | 4.71 |
| Enterprise value/revenue | 65.20 |
| Enterprise value/EBITDA | 0.72 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.11 |
| 52-week change 3 | -17.39% |
| S&P500 52-week change 3 | 23.99% |
| 52-week high 3 | 0.7500 |
| 52-week low 3 | 0.3100 |
| 50-day moving average 3 | 0.4352 |
| 200-day moving average 3 | 0.4638 |
Share statistics
| Avg vol (3-month) 3 | 253.22k |
| Avg vol (10-day) 3 | 222.38k |
| Shares outstanding 5 | 51.28M |
| Implied shares outstanding 6 | 51.28M |
| Float 8 | 46.71M |
| % held by insiders 1 | 8.01% |
| % held by institutions 1 | 7.16% |
| Shares short (15 May 2024) 4 | 433.19k |
| Short ratio (15 May 2024) 4 | 2.49 |
| Short % of float (15 May 2024) 4 | 0.87% |
| Short % of shares outstanding (15 May 2024) 4 | 0.84% |
| Shares short (prior month 15 Apr 2024) 4 | 477.18k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 11 Jun 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:44 |
| Last split date 3 | 11 Jun 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -14,335.00% |
Management effectiveness
| Return on assets (ttm) | -77.71% |
| Return on equity (ttm) | -156.31% |
Income statement
| Revenue (ttm) | 193k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | -18.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -33.11M |
| Net income avi to common (ttm) | -31.12M |
| Diluted EPS (ttm) | -0.6400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 10.94M |
| Total cash per share (mrq) | 0.21 |
| Total debt (mrq) | 3.35M |
| Total debt/equity (mrq) | 69.42% |
| Current ratio (mrq) | 1.14 |
| Book value per share (mrq) | 0.08 |
Cash flow statement
| Operating cash flow (ttm) | -22.4M |
| Levered free cash flow (ttm) | -12.67M |
© 2024 Yahoo. All rights reserved.